Ahmed Saad Abdlkadir, Florian Rosar, Amireza Jalilian, Serin Moghrabi, Batool Al-Balooshi, Obayda Rabei, Kalevi Kairemo, Akram Al-Ibraheem
{"title":"利用铽放射性同位素促进临床进展:系统综述。","authors":"Ahmed Saad Abdlkadir, Florian Rosar, Amireza Jalilian, Serin Moghrabi, Batool Al-Balooshi, Obayda Rabei, Kalevi Kairemo, Akram Al-Ibraheem","doi":"10.1007/s13139-024-00891-0","DOIUrl":null,"url":null,"abstract":"<p><p>Background this systematic review was conducted to assess the practical application of terbium radioisotopes, utilizing systematic search methodologies to identify relevant studies. Methods the databases of PubMed, Web of Science, and Scopus were systematically scoured, targeting the research on four terbium isotopes: <sup>149</sup> Tb, <sup>152</sup> Tb, <sup>155</sup> Tb, and <sup>161</sup> Tb. Various combinations of keywords related to terbium and its four radioisotopes were used in the search process. The search encompassed studies conducted up to July 27, 2024. Results following the removal of 335 duplicate research articles, a cohort of 429 papers was curated for potential inclusion in the study. Out of 429 articles reviewed, a mere nine addressed the potential uses of <sup>161</sup> Tb and <sup>152</sup> Tb. Notably, <sup>155</sup> Tb and <sup>149</sup> Tb have yet to be examined in human subjects. Conclusions the research trajectory is now veering towards clinical studies that provide in-human data, with the goal of advancing radiotheranostics and nuclear oncology. The preliminary outcomes are stimulating and have led to the initiation of several clinical trials. The success of these trials and the establishment of production facilities will be critical for the clinical adoption of these agents.</p>","PeriodicalId":19384,"journal":{"name":"Nuclear Medicine and Molecular Imaging","volume":"59 1","pages":"50-61"},"PeriodicalIF":1.3000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11772629/pdf/","citationCount":"0","resultStr":"{\"title\":\"Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic Review.\",\"authors\":\"Ahmed Saad Abdlkadir, Florian Rosar, Amireza Jalilian, Serin Moghrabi, Batool Al-Balooshi, Obayda Rabei, Kalevi Kairemo, Akram Al-Ibraheem\",\"doi\":\"10.1007/s13139-024-00891-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Background this systematic review was conducted to assess the practical application of terbium radioisotopes, utilizing systematic search methodologies to identify relevant studies. Methods the databases of PubMed, Web of Science, and Scopus were systematically scoured, targeting the research on four terbium isotopes: <sup>149</sup> Tb, <sup>152</sup> Tb, <sup>155</sup> Tb, and <sup>161</sup> Tb. Various combinations of keywords related to terbium and its four radioisotopes were used in the search process. The search encompassed studies conducted up to July 27, 2024. Results following the removal of 335 duplicate research articles, a cohort of 429 papers was curated for potential inclusion in the study. Out of 429 articles reviewed, a mere nine addressed the potential uses of <sup>161</sup> Tb and <sup>152</sup> Tb. Notably, <sup>155</sup> Tb and <sup>149</sup> Tb have yet to be examined in human subjects. Conclusions the research trajectory is now veering towards clinical studies that provide in-human data, with the goal of advancing radiotheranostics and nuclear oncology. The preliminary outcomes are stimulating and have led to the initiation of several clinical trials. The success of these trials and the establishment of production facilities will be critical for the clinical adoption of these agents.</p>\",\"PeriodicalId\":19384,\"journal\":{\"name\":\"Nuclear Medicine and Molecular Imaging\",\"volume\":\"59 1\",\"pages\":\"50-61\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11772629/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nuclear Medicine and Molecular Imaging\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13139-024-00891-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear Medicine and Molecular Imaging","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13139-024-00891-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
摘要
背景:本系统综述旨在评估铽放射性同位素的实际应用,利用系统检索方法识别相关研究。方法系统检索PubMed、Web of Science和Scopus数据库,对149tb、152tb、155tb和161tb四种铽同位素进行研究。在搜索过程中使用了与铽及其四种放射性同位素相关的各种关键字组合。这项研究涵盖了截至2024年7月27日的研究。结果:在删除335篇重复研究文章后,429篇论文被筛选为潜在的研究对象。在被审查的429篇文章中,只有9篇提到了161 Tb和152 Tb的潜在用途。值得注意的是,155 Tb和149 Tb尚未在人类受试者中进行检测。研究轨迹现在正转向提供人体数据的临床研究,目标是推进放射治疗学和核肿瘤学。初步结果令人振奋,并导致了几项临床试验的启动。这些试验的成功和生产设施的建立对于这些药物的临床应用至关重要。
Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic Review.
Background this systematic review was conducted to assess the practical application of terbium radioisotopes, utilizing systematic search methodologies to identify relevant studies. Methods the databases of PubMed, Web of Science, and Scopus were systematically scoured, targeting the research on four terbium isotopes: 149 Tb, 152 Tb, 155 Tb, and 161 Tb. Various combinations of keywords related to terbium and its four radioisotopes were used in the search process. The search encompassed studies conducted up to July 27, 2024. Results following the removal of 335 duplicate research articles, a cohort of 429 papers was curated for potential inclusion in the study. Out of 429 articles reviewed, a mere nine addressed the potential uses of 161 Tb and 152 Tb. Notably, 155 Tb and 149 Tb have yet to be examined in human subjects. Conclusions the research trajectory is now veering towards clinical studies that provide in-human data, with the goal of advancing radiotheranostics and nuclear oncology. The preliminary outcomes are stimulating and have led to the initiation of several clinical trials. The success of these trials and the establishment of production facilities will be critical for the clinical adoption of these agents.
期刊介绍:
Nuclear Medicine and Molecular Imaging (Nucl Med Mol Imaging) is an official journal of the Korean Society of Nuclear Medicine, which bimonthly publishes papers on February, April, June, August, October, and December about nuclear medicine and related sciences such as radiochemistry, radiopharmacy, dosimetry and pharmacokinetics / pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. The journal specially welcomes works of artificial intelligence applied to nuclear medicine. The journal will also welcome original works relating to molecular imaging research such as the development of molecular imaging probes, reporter imaging assays, imaging cell trafficking, imaging endo(exo)genous gene expression, and imaging signal transduction. Nucl Med Mol Imaging publishes the following types of papers: original articles, reviews, case reports, editorials, interesting images, and letters to the editor.
The Korean Society of Nuclear Medicine (KSNM)
KSNM is a scientific and professional organization founded in 1961 and a member of the Korean Academy of Medical Sciences of the Korean Medical Association which was established by The Medical Services Law. The aims of KSNM are the promotion of nuclear medicine and cooperation of each member. The business of KSNM includes holding academic meetings and symposia, the publication of journals and books, planning and research of promoting science and health, and training and qualification of nuclear medicine specialists.